Verona Pharma PLC ADR
Price & Volume
Stats
See more52W Range | $31.60-$106.93 |
Market Cap | $9B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $221.6M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $210.9M |
Diluted EPS | -$1.04 |
News
See moreYahoo Finance • 4 days ago
Verona Pharma plc (VRNA)’s Shareholders Authorizes the $10 Billion Acquisition of Verona Pharma plc (VRNA); Nasdaq Trading to Suspend
Yahoo Finance • 5 days ago
VRNA Quantitative Stock Analysis
Yahoo Finance • 6 days ago
Aehr Test Systems Non-GAAP EPS of $0.01, revenue of $11M beats by $0.23M
Yahoo Finance • 6 days ago
Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales
About
CEO | Dr. David Scott Zaccardelli Pharm.D. |
Address | 3 More London Riverside, London, United Kingdom, SE1 2RE |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 209 |
